Veradermics VDPHL01: why isn’t anyone talking about it?
    Treatment 12/14/2024

    At a glance
    In this question or advice post, the primary subjects mentioned are the tone is 😐 neutral with no improvement results.

    Other terms

    Veradermics' new hair loss treatment, VDPHL01, is likely a modified release oral minoxidil, which has received $75 million in funding for clinical trials. Despite skepticism about investing in a known treatment, some believe it could offer improved efficacy and reduced side effects.
    View this post in the Community →

    Similar Community Posts Join

    3 / 4 results

      community What to look Forward to in 2025

      in Research/Science  17 upvotes 3 weeks ago
      Hair loss treatments are advancing, with Coegin Pharma's FOL005 expected this year and Breezula potentially later. Pyrilutamide is available but not very effective, while Kintor's products face skepticism; traditional treatments like finasteride and minoxidil remain dominant.

      community Horrible news, Stemson Therapeutics has shut down

      in Technology  193 upvotes 2 months ago
      Stemson Therapeutics has shut down, disappointing those seeking a hair loss cure. Current treatments like minoxidil, finasteride, and dutasteride are discussed, with some users experiencing side effects and exploring alternatives like PP405.

    Related Research

    0 / 0 results
    — no results